Delivery Order SPE2DR25D3301-SPE2DR26F22VC
Award Date 2/20/26
Potential Completion Date 2/23/26
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Latuda 60 mg tablets (30-count units) with a ceiling value of $29,470.00 under firm fixed pricing. This non-set-aside, competitively awarded delivery order is scheduled for completion by August 5, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Latuda 120 mg tablets (30-count packages) under a firm fixed-price contract with a ceiling value of $9,820.56. The order is scheduled for completion by November 21, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the contractor's proven...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Latuda 80 mg tablets (30-count units) with a ceiling value of $5,922.45. This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, represents a single transaction under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The award was competitively procured with no set-aside designation, and...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on September 2, 2025, for the supply of Latuda 60 mg tablets (30-count packaging) with a ceiling value of $6,445.00 under a firm fixed price contract. This non-set-aside award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which carries a total value of $999,999,999.00 and extends through December 2026. The order is to be fulfilled...
- The Defense Logistics Agency awarded a delivery order valued at $4,755.09 to AmerisourceBergen Drug Corp for the supply of Latuda 20 mg tablets (30-count packaging) on September 22, 2025, with completion expected by September 23, 2025. This firm fixed-price contract, with no set-aside designation, represents a routine pharmaceutical procurement supporting federal medical supply needs. The award was made to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Latuda 40 mg tablets (quantity: 30 units) under a firm fixed price contract with a ceiling value of $10,349.66. The order is scheduled for completion by September 23, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a...
- The Defense Logistics Agency awarded a delivery order valued at approximately $29.2K to AmerisourceBergen Drug Corp for the supply of Latuda 20 mg tablets (30-count packages) on January 27, 2026, with a completion date of January 28, 2026. This competitive, non-set-aside award was issued under firm fixed-price terms and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,377.96 to AmerisourceBergen Drug Corp for the supply of Latuda 120 mg tablets (30-count package) under a firm fixed-price contract. The award was issued on November 7, 2025, with an ultimate completion date of November 10, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This non-competitive delivery order represents a small-value pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Latuda 40 mg tablets (30-count units) valued at $7,754.48 under a firm fixed price contract structure. This non-set-aside award was competitively procured and is scheduled for completion by July 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and will fulfill this order...
- The Defense Logistics Agency awarded a delivery order valued at $9,844.52 to AmerisourceBergen Drug Corp for the supply of Latuda 40 mg tablets (30-count packages) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitively awarded transaction under the company's broader pharmaceutical supply relationships with the federal government. The product will be delivered to AmerisourceBergen's...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F22VCDelivery Order
The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 20, 2026, with a ceiling value of $13,121.87 for supply of Latuda 20 mg tablets (30-count). Place of performance is Conshohocken, PA. Ultimate completion date is February 23, 2026.
Generated 5/22/26, 9:53 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.1k | 2/19/26 |